BIO Applauds Reauthorization of SCHIP
WASHINGTON, D.C. (Thursday, February 05, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today praising the reauthorization of the State Children’s Health Insurance Program (SCHIP):
“BIO and its member companies applaud President Barack Obama and Congress for reauthorizing SCHIP. This legislation is important because it covers those who cannot cover themselves – America’s children.
“BIO supports universal access to affordable, sustainable, high-quality health care for all. It is critical that all individuals be insured for the benefit of the entire health care system and that they have access to critical life-saving preventative care measures, such as immunizations, early detection and screening.
“BIO and its member companies are committed to expanding the boundaries of science by discovering, developing and delivering innovative therapies to patients including the millions of children around the world who suffer from diseases for which there is no treatment or cure. However, BIO can only help achieve this goal if effective and sustainable solutions are provided to ensure that more people secure health care coverage while maintaining incentives for future innovation.
"BIO welcomes the opportunity to continue to work with policymakers and other stakeholders on ways to improve access to innovative medical therapies, and to ensure that the most appropriate care is delivered to each patient.”
Upcoming BIO Events
BIO CEO & Investor Conference 2009
February 9-10, 2009
New York, New York
BIO-Europe Spring
March 16-18, 2009
Milan, Italy
BIO IP Counsels' Committee Conference
March 25–27, 2009
Phoenix, AZ
BIO National Venture Conference
March 31–April 1,2009
Boston, MA
BIO Windhover 2009
April 13-15, 2009
New York, New York
BIO-LES Business Development Basics Course
May 15–17, 2009
Atlanta, GA
BIO-LES Advanced Business Development Course
May 15–17, 2009
Atlanta, GA
BIO Executive Presentation Workshop
May 17, 2009
Atlanta, GA
2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.
BioEquity Europe
June 9-10, 2009
Munich, Germany
World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###
“BIO and its member companies applaud President Barack Obama and Congress for reauthorizing SCHIP. This legislation is important because it covers those who cannot cover themselves – America’s children.
“BIO supports universal access to affordable, sustainable, high-quality health care for all. It is critical that all individuals be insured for the benefit of the entire health care system and that they have access to critical life-saving preventative care measures, such as immunizations, early detection and screening.
“BIO and its member companies are committed to expanding the boundaries of science by discovering, developing and delivering innovative therapies to patients including the millions of children around the world who suffer from diseases for which there is no treatment or cure. However, BIO can only help achieve this goal if effective and sustainable solutions are provided to ensure that more people secure health care coverage while maintaining incentives for future innovation.
"BIO welcomes the opportunity to continue to work with policymakers and other stakeholders on ways to improve access to innovative medical therapies, and to ensure that the most appropriate care is delivered to each patient.”
Upcoming BIO Events
BIO CEO & Investor Conference 2009
February 9-10, 2009
New York, New York
BIO-Europe Spring
March 16-18, 2009
Milan, Italy
BIO IP Counsels' Committee Conference
March 25–27, 2009
Phoenix, AZ
BIO National Venture Conference
March 31–April 1,2009
Boston, MA
BIO Windhover 2009
April 13-15, 2009
New York, New York
BIO-LES Business Development Basics Course
May 15–17, 2009
Atlanta, GA
BIO-LES Advanced Business Development Course
May 15–17, 2009
Atlanta, GA
BIO Executive Presentation Workshop
May 17, 2009
Atlanta, GA
2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.
BioEquity Europe
June 9-10, 2009
Munich, Germany
World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###